Home » Topics » BioWorld Science

BioWorld Science
RSS

XtalPi and Pfizer enter research collaboration

May 9, 2018

Alnylam achieves delivery of siRNA conjugates to CNS

May 9, 2018

Promising phase II results for TOP-1630 in dry eye syndrome

May 9, 2018

Celgene presents highlights of first quarter 2018

May 9, 2018

Biohaven establishes expanded access program for sublingual BHV-0223 for ALS

May 9, 2018

Atara Biotherapeutics expands collaboration with Memorial Sloan Kettering

May 9, 2018

Researchers present INT-1B3 as a promising antitumoral compound

May 9, 2018

Phase III TAGS trial of Lonsurf in metastatic gastric cancer meets primary endpoint

May 9, 2018

Alternative targeting of IDO pathway: New developments from the AAI annual meeting

May 9, 2018

Novo Nordisk reviews pipeline highlights of first quarter 2018

May 9, 2018

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...